| Literature DB >> 31334385 |
Han Kim1, Michele C Lim1, Mark J Mannis1, Esther S Kim1.
Abstract
PURPOSE: To present the case of a 72-year-old female with epithelial downgrowth after femtosecond laser-assisted cataract surgery. OBSERVATIONS: The patient previously underwent YAG vitreolysis after uncomplicated femtosecond laser-assisted cataract surgery and presented 1 year later with epithelial downgrowth causing complete pupillary block and severe angle closure glaucoma. Subsequent management with nd:YAG peripheral iridotomies failed rapidly leading to a confusing presentation with a flat anterior chamber and high intraocular pressure ultimately requiring surgical management.Entities:
Keywords: Epithelial downgrowth; Epithelial ingrowth; Femtosecond laser-assisted cataract surgery; Pupillary block; Pupillary membrane; Secondary angle closure glaucoma; Ultrasound biomicroscopy; nd:YAG capsulotomy
Year: 2019 PMID: 31334385 PMCID: PMC6616539 DOI: 10.1016/j.ajoc.2019.100507
Source DB: PubMed Journal: Am J Ophthalmol Case Rep ISSN: 2451-9936
Fig. 1Slit lamp photo of the right eye depicting near complete pupillary occlusion with a darkly pigmented membrane. White arrow points to pinhole opening.
Fig. 2A) Broad peripheral anterior synechiae and neovascular membrane across the temporal angle of the right eye B) Anterior segment optical coherence tomography imaging showing a membranous sheet-like growth on the iris and extending into the angle.
Fig. 3A) Severe neovascularization with complete pupillary block, closure of 2 prior peripheral iridotomies (white arrows) and a B) flat anterior chamber.
Fig. 4A) Ultrasound biomicroscopic (UBM) appearance of the anterior and posterior chamber upon first presentation. B) Subsequent UBM with obliteration of anterior chamber with iris pressed directly up against the cornea and a large posterior chamber with stable intraocular lens.
Fig. 5A) Hematoxylin & Eosin staining of epithelial tissue lining iris tissue and B) positive immunohistochemical staining with AE1-AE3 (anti-cytokeratin monoclonal antibodies).